These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 8241102

  • 21. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
    Hedrick CC, Hassan K, Hough GP, Yoo JH, Simzar S, Quinto CR, Kim SM, Dooley A, Langi S, Hama SY, Navab M, Witztum JL, Fogelman AM.
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
    [Abstract] [Full Text] [Related]

  • 22. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.
    Williamson R, Lee D, Hagaman J, Maeda N.
    Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):7134-8. PubMed ID: 1496008
    [Abstract] [Full Text] [Related]

  • 23. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL, Loeb SM, Weisgraber KH.
    Arterioscler Thromb Vasc Biol; 2005 Feb 01; 25(2):436-41. PubMed ID: 15591220
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synthetic low and high fat diets for the study of atherosclerosis in the mouse.
    Nishina PM, Verstuyft J, Paigen B.
    J Lipid Res; 1990 May 01; 31(5):859-69. PubMed ID: 2380634
    [Abstract] [Full Text] [Related]

  • 26. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.
    Liu AC, Lawn RM, Verstuyft JG, Rubin EM.
    J Lipid Res; 1994 Dec 01; 35(12):2263-7. PubMed ID: 7897323
    [Abstract] [Full Text] [Related]

  • 27. Genetic susceptibility and resistance to diet-induced atherosclerosis and hyperlipoproteinemia.
    Morrisett JD, Kim HS, Patsch JR, Datta SK, Trentin JJ.
    Arteriosclerosis; 1982 Dec 01; 2(4):312-24. PubMed ID: 7115205
    [Abstract] [Full Text] [Related]

  • 28. Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.
    Kawashiri MA, Zhang Y, Puré E, Rader DJ.
    Atherosclerosis; 2002 Nov 01; 165(1):15-22. PubMed ID: 12208466
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE, Navab M, Millar JS, Zimetti F, Hama S, Rothblat GH, Rader DJ.
    Circ Res; 2005 Oct 14; 97(8):763-71. PubMed ID: 16151025
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.
    Zhang SH, Reddick RL, Avdievich E, Surles LK, Jones RG, Reynolds JB, Quarfordt SH, Maeda N.
    J Clin Invest; 1997 Jun 15; 99(12):2858-66. PubMed ID: 9185508
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P, Schaefer EJ, McConathy WJ, Fesmire JD, Brewer HB.
    Metabolism; 1981 Aug 15; 30(8):805-9. PubMed ID: 6790903
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.